These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23026534)

  • 21. Epigenetics, oxidative stress, and Alzheimer disease.
    Zawia NH; Lahiri DK; Cardozo-Pelaez F
    Free Radic Biol Med; 2009 May; 46(9):1241-9. PubMed ID: 19245828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevention of the dementia epidemic.
    Korczyn AD; Vakhapova V
    J Neurol Sci; 2007 Jun; 257(1-2):2-4. PubMed ID: 17490685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular risk profiles for dementia and Alzheimer's disease in very old people: a population-based longitudinal study.
    Qiu C; Xu W; Winblad B; Fratiglioni L
    J Alzheimers Dis; 2010; 20(1):293-300. PubMed ID: 20164587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic mechanisms of amyloid-β production in anisomycin-treated SH-SY5Y cells.
    Guo X; Wu X; Ren L; Liu G; Li L
    Neuroscience; 2011 Oct; 194():272-81. PubMed ID: 21843603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bridging the pathophysiology of Alzheimer's disease with vascular pathology: the feed-back, the feed-forward, and oxidative stress.
    Polidori MC; Pientka L
    J Alzheimers Dis; 2012; 28(1):1-9. PubMed ID: 22002788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is 'early onset dementia'?
    Miyoshi K
    Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular risk factor detection and control may prevent Alzheimer's disease.
    de la Torre JC
    Ageing Res Rev; 2010 Jul; 9(3):218-25. PubMed ID: 20385255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease?
    Isingrini E; Desmidt T; Belzung C; Camus V
    Curr Opin Investig Drugs; 2009 Jan; 10(1):46-55. PubMed ID: 19127486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.
    Aliev G; Smith MA; de la Torre JC; Perry G
    Mitochondrion; 2004 Sep; 4(5-6):649-63. PubMed ID: 16120422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension and cognitive function.
    Paglieri C; Bisbocci D; Caserta M; Rabbia F; Bertello C; Canadè A; Veglio F
    Clin Exp Hypertens; 2008 Nov; 30(8):701-10. PubMed ID: 19021021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are mitochondria critical in the pathogenesis of Alzheimer's disease?
    Reddy PH; Beal MF
    Brain Res Brain Res Rev; 2005 Nov; 49(3):618-32. PubMed ID: 16269322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular risk factors and progression in Alzheimer's disease.
    Sakurai H; Hanyu H; Sato T; Kanetaka H; Shimizu S; Hirao K; Kikukawa M; Iwamoto T
    Geriatr Gerontol Int; 2011 Apr; 11(2):211-4. PubMed ID: 21143566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The imbalance of vascular molecules in Alzheimer's disease.
    Bell RD
    J Alzheimers Dis; 2012; 32(3):699-709. PubMed ID: 22850315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice.
    Cuadrado-Tejedor M; Ricobaraza A; Frechilla D; Franco R; Pérez-Mediavilla A; Garcia-Osta A
    J Alzheimers Dis; 2012; 28(3):567-78. PubMed ID: 22045482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.